Radcliffe Capital Management, L.P. - CLARUS THERAPEUTICS HLDNGS I ownership

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 21 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q3 2021$371,00070,8930.01%
Other shareholders

There were no reported owners of CLARUS THERAPEUTICS HLDNGS I in Q4 2021.

NameSharesValueWeighting ↓
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders